종합 밸류에이션 구간 · 보수적 35–42 / 적정 43–52 / 낙관적 55–65. 50.6 기준, 적정 내재가치 구간 내.
보고서 발행 시 51.45（2026년 6월 8일）
이 종목에 대한 리포트가 아직 해당 언어로 없습니다.
Renishaw plc, an engineering and scientific technology company, designs, manufactures, distributes, sells, and services technological products and services, and analytical instruments and medical devices worldwide. It operates through two segments: Manufacturing technologies; and Analytical instruments and medical devices. The company offers precision measurement and process control products, such as co-ordinate measuring machine probes, software, retrofits, equator gauging systems, fixtures, machine calibration and optimization, machine tool probes, precision styli for metrology, and smart manufacturing data platform; and position and motion control products comprising interferometric laser, magnetic, and optical encoders. It also provides healthcare products, such as neuromate stereotactic robots, neuroinfuse drug delivery systems, neuroinspire surgical planning software, dixi medical's, and Raman spectrometers; industrial robots; and additive 3D printing manufacturing systems. It serves the aerospace, automotive, consumer electronics, medical and healthcare, heavy, machine builder, energy, and precision manufacturing industries, as well as scientific, research, and analysis industries. The company was incorporated in 1973 and is based in Wotton-under-Edge, the United Kingdom.
데이터 제공: EODHD, 보고 통화 기준 표시. 참고용일 뿐 투자 자문이 아닙니다.
연혁
준비 중이 섹션은 작성 중입니다. 곧 다시 확인해 주세요.
업계 내 위치
준비 중이 섹션은 작성 중입니다. 곧 다시 확인해 주세요.